Veracyte Stock - chart picture and technical levels on the Nasdaq
18.06.2026 - 16:32:51 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:30 CET. Details in the imprint.
Veracyte (US92347M1009) is a US-based diagnostics company whose stock is listed on the Nasdaq. With no fresh company or market-moving news from major wires or investor relations today, the chart and key technical levels take center stage for this Thursday update.
All news and background on Veracyte stock
Price data, regulatory filings and earlier company announcements on Veracyte can be found bundled on the dedicated stock topic page and on the company’s investor relations site.
How the Veracyte chart looks
Without a fresh earnings release, deal announcement or analyst rating change today, Veracyte’s chart offers the clearest reading on sentiment. The stock has shown periods of notable volatility over recent quarters as investors digested diagnostics demand trends and reimbursement developments.
The Standard & Poor's 500 index and the broader Nasdaq biotechnology segment provide the backdrop, but Veracyte’s own path has at times diverged. Day-to-day moves have been shaped more by company-specific expectations than by the overall market direction.
The 200-day line and volatility
On a technical view, many market participants watch where Veracyte shares sit relative to long-term moving averages such as the 200-day line. That reference level often serves as a rough dividing line between longer phases of strength and periods of consolidation.
Traders also monitor how wide the typical trading range has been in recent weeks. A tighter band around the current price can indicate a more balanced tug of war between buyers and sellers, while a broader range often coincides with shifting expectations and higher uncertainty.
The business behind the ticker
Veracyte generates its revenue with genomic diagnostic tests that help physicians clarify cancer and other disease diagnoses from patient samples. The company focuses on improving diagnostic accuracy in indications such as lung cancer and thyroid nodules, aiming to reduce unnecessary procedures.
Where the stock trades today
Veracyte stock (US92347M1009) trades on the Nasdaq in US dollars; the most recently verified quote and detailed intraday data are available directly from the Nasdaq and major financial data providers.
Key facts on Veracyte stock
- Company: Veracyte Inc.
- ISIN: US92347M1009
- WKN: A2N6MJ
- Ticker: VCYT
- Venue: Nasdaq
- Sector / Industry: Health Care / Diagnostics & Research
- Index membership: not a constituent of major headline indices such as the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
